Wednesday - January 28, 2026

Category Archives: Business

Hemophilia B Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Novo Nordisk, Sanofi, Pfizer, Belief BioMed, Centessa Pharmaceuticals

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary Arterial Hypertension treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Gorlin Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome pipeline landscape. It covers the Gorlin Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Duchenne Muscular Dystrophy Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

PH-ILD Market Size in the 7MM was ~USD 3 Billion in 2024 and is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Pulmonary Hypertension associated Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Pulmonary Hypertension associated Interstitial Lung Disease, historical and forecasted epidemiology and the Pulmonary Hypertension associated Interstitial Lung Disease … Continue reading →

Wiskott-Aldrich Syndrome Market to Evolve Rapidly Over the Next Decade, DelveInsight Observes | GlaxoSmithKline, Orchard Therapeutics, Genethon

Wiskott-Aldrich Syndrome Market Insights, Epidemiology, and Market Forecast-2032 The Key Wiskott-Aldrich Syndrome Companies in the market include – GlaxoSmithKline, Orchard Therapeutics, Genethon, Grifols Therapeutics LLC, Soma Jyonouchi, and others. The Wiskott-Aldrich Syndrome market is expected to surge due to the … Continue reading →